Retail Investors Pile into QuantumPharm's IPO in Hong Kong
Tuesday, 4 June 2024, 09:59
QuantumPharm IPO Oversubscribed 10 Times
Retail investors have rushed to subscribe to Tencent-backed AI drug researcher QuantumPharm on the first day of its HK$1.13 billion (US$144.5 million) IPO, encouraged by recent market rallies and listing reforms.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.